Wegovy vs Mounjaro: Which Treatment Suits You?
Can I Switch From Wegovy to Mounjaro: Key Mechanism Differences
Understanding whether you can switch from Wegovy to Mounjaro begins with recognising their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones to reduce appetite and promote satiety after smaller meals. Mounjaro utilises tirzepatide, a dual GIP and GLP-1 receptor agonist that activates two complementary hormone pathways simultaneously. This dual mechanism may offer different appetite control patterns, though individual responses vary significantly between patients.
When considering whether you can switch from Wegovy to Mounjaro, your prescriber will evaluate your current treatment response, any side effects experienced, and your weight management goals. The transition typically requires a structured approach, potentially including a washout period and careful dose escalation with the new medication. Both prescription-only medicines require ongoing clinical supervision and must be used alongside lifestyle modifications including reduced-calorie diet and increased physical activity for optimal licensed outcomes.
Pricing Comparison: Wegovy vs Mounjaro Treatment Costs
Cost considerations often influence decisions about switching from Wegovy to Mounjaro, with both treatments available through EverydayMeds at competitive pricing. Wegovy single pens range from £79.99 for the 0.25mg starter dose to £209.99 for the 2.4mg maintenance strength, whilst our bundle options provide convenient multi-month supplies like the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99. New customers can apply code FIRST40 at checkout, whilst returning patients use DOSE25 for additional savings on their orders.
Mounjaro pricing follows a different structure due to its unique dosing schedule, with six available strengths from 2.5mg to 15mg maximum dose. When evaluating whether to switch from Wegovy to Mounjaro based on cost-effectiveness, consider the complete treatment journey including potential differences in time to reach effective doses. Both medications require prescription-only access through clinical assessment, with standard prescriber review taking three working days or express 24-hour service available for urgent requirements.
Clinical Evidence: STEP Trials vs Mounjaro Research
Clinical evidence supports both Wegovy and Mounjaro for weight management, though direct head-to-head comparisons remain limited due to different trial designs and patient populations. Wegovy's STEP programme demonstrated significant weight reduction outcomes, with STEP 1 showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise modifications (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further evidenced a 20% reduction in major cardiovascular events with semaglutide treatment.
Mounjaro's clinical programme utilised different endpoints and methodologies, making direct percentage comparisons inappropriate for determining whether you should switch from Wegovy to Mounjaro. Your prescriber can review the specific evidence relevant to your individual circumstances, including any comorbidities, previous treatment responses, and cardiovascular risk factors that may influence optimal medication selection for your weight management journey.
How Wegovy Works: GLP-1 Receptor Mechanism
Wegovy's mechanism centres on GLP-1 receptor agonism, mimicking the action of glucagon-like peptide-1, a naturally occurring incretin hormone released after eating. This hormone signals satiety to the brain, reduces gastric emptying to prolong fullness feelings, and may diminish food cravings by acting on appetite centres in the hypothalamus. The once-weekly FlexTouch pen delivery system maintains consistent therapeutic levels, providing sustained appetite suppression between doses. Wegovy requires mandatory dose escalation starting at 0.25mg for four weeks, progressing through 0.5mg, 1mg, and 1.7mg phases before reaching the 2.4mg maintenance dose at week 17. This gradual titration helps minimise gastrointestinal side effects whilst allowing patients to adapt to the medication's appetite-suppressing effects progressively.
Ordering Process: Clinical Assessment to Delivery
Accessing either Wegovy or Mounjaro through EverydayMeds begins with our comprehensive 3-minute online clinical assessment, designed to capture your medical history, current medications, weight management goals, and any relevant contraindications. Our qualified prescribers review each assessment individually, typically within three working days, though express 24-hour review is available for urgent cases. Once approved, your prescription-only medicine is dispensed from our GPhC-registered pharmacy (#9012878) and dispatched via next-day delivery using cold-chain, temperature-controlled packaging. Our clinical team remains available throughout your treatment journey to address questions about switching from Wegovy to Mounjaro or optimising your current therapy. All orders include detailed administration guides, storage instructions, and access to ongoing clinical support for dose adjustments or side effect management.
Storage and Practical Considerations
Storage requirements differ between Wegovy and Mounjaro, potentially influencing your decision about switching treatments. Wegovy offers superior travel convenience, remaining stable at room temperature (below 30°C) for up to six weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require refrigerated storage at 2-8°C before first use and should never be frozen or exposed to direct sunlight. The FlexTouch pen system used for Wegovy provides precise dose delivery with clear dose windows and audible click confirmation when injection is complete. Weekly injection scheduling remains consistent regardless of whether you switch from Wegovy to Mounjaro, though the specific injection day may be adjusted during transition periods. Proper disposal of used pens follows standard sharps waste protocols, with disposal containers available through community pharmacies nationwide.
Switching Considerations: Medical Supervision Requirements
The decision about whether you can switch from Wegovy to Mounjaro requires careful medical evaluation, as both medications affect similar physiological pathways despite their distinct mechanisms. Your prescriber will assess current treatment efficacy, documented side effects, adherence patterns, and individual risk factors before recommending any medication transition. Some patients may require a structured washout period between treatments to minimise potential interactions or compounded side effects.
Timing considerations include your current dose level, duration of previous treatment, and any planned lifestyle changes that might affect treatment response. The switch from Wegovy to Mounjaro typically involves restarting dose escalation protocols, as the medications use different dosing schedules and strength progressions. Close monitoring during transition periods helps identify any unusual responses and ensures optimal therapeutic outcomes throughout the switching process.
Treatment Access Through EverydayMeds
Both Wegovy and Mounjaro are available exclusively through EverydayMeds, providing patients considering switching with seamless access to expert clinical guidance and comparative treatment options. Our prescribers can evaluate your complete treatment history, current progress, and individual circumstances to determine whether switching from Wegovy to Mounjaro aligns with your weight management objectives. Comprehensive clinical records ensure continuity of care throughout any treatment transitions, with detailed documentation of dosing progressions, side effect profiles, and efficacy outcomes. Access our complete weight management collection at https://everydaymeds.co.uk/collections/weight-loss to explore both treatment options with competitive pricing, convenient bundle packages, and expert clinical support throughout your weight management journey. Remember to apply discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout for additional savings on your prescription-only medicine orders.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
